We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

63 hedge funds and large institutions have $287M invested in First Trust NYSE Arca Biotechnology Index Fund in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

85.09% more ownership

Funds ownership: 0%85.09% (+85%)

16% less call options, than puts

Call options by funds: $1.28M | Put options by funds: $1.52M

Holders
63
Holders Change
+63
Holders Change %
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
63
Increased
Reduced
Closed
Calls
$1.28M
Puts
$1.52M
Net Calls
-$244K
Net Calls Change
-$244K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

FBT Hedge Fund Activity: Q2 2013 in Review

63 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2013, worth a combined $287M.

Buyers outnumbered sellers: 63 funds opened new FBT positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.

  • 63 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $287M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2013.
  • 63 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2013 and 0 closed out, a net change of +63 holders.

Based on aggregated 13F filings for Q2 2013.